Botulinum Toxin Type B Product Approval Information - Licensing Action

Proper name: Botulinum Toxin Type B
Tradename: MYOBLOC
Manufacturer: Elan Pharmaceuticals, South San Francisco, CA, License #1579
Indication for Use: Treatment of cervical dystonia to reduce the severity of abnormal head position and neck pain
Approval Date: 12/08/2000
Type of submission: Biologics license application


Approval Letter (PDF)

Labeling (PDF)

Statistical Review (PDF)

Supplemental Clinical Review (PDF)

Chemistry, Manufacturing, and Controls Section Review (PDF)

Clinical Review (PDF)

Page Last Updated: 04/06/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English